Provided by Tiger Fintech (Singapore) Pte. Ltd.

ResMed

291.44
+12.244.38%
Post-market: 291.440.00000.00%16:10 EDT
Volume:1.55M
Turnover:448.02M
Market Cap:42.66B
PE:30.65
High:293.08
Open:279.00
Low:278.22
Close:279.20
Loading ...

Analysts Offer Insights on Healthcare Companies: Sigma Healthcare Ltd (S5YA) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX: AU:RMD)

TIPRANKS
·
Yesterday

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Ord Minnett

TIPRANKS
·
Yesterday

ResMed CFO, Chief Legal Officer Sells Shares

MT Newswires Live
·
Yesterday

ResMed Inc Announces Proposed Sale of Common Shares

TIPRANKS
·
Yesterday

Resmed Inc-144 Report of Proposed Sale of Securities

THOMSON REUTERS
·
Yesterday

144 Report of proposed sale of securities-RMD.N

Reuters
·
Yesterday

Resmed Inc-Departure of Directors or Certain Officers

THOMSON REUTERS
·
Yesterday

Departure of Directors or Certain Officers-RMD.N

Reuters
·
Yesterday

ResMed Full Year 2025 Earnings: EPS Beats Expectations

Simply Wall St.
·
03 Aug

Top Traditional IRA Mistakes and How to Avoid Them

Motley Fool
·
03 Aug

How Much Is the Required Minimum Distribution (RMD) if You Have $500,000 in Your Retirement Accounts?

Motley Fool
·
03 Aug

Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (BLCO), Resmed (RMD) and Envista Holdings (NVST)

TIPRANKS
·
02 Aug

ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast

Reuters
·
02 Aug

ResMed Is Maintained at Overweight by Keybanc

Dow Jones
·
01 Aug

ResMed price target raised to $270 from $240 at Stifel

TIPRANKS
·
01 Aug

ResMed price target raised to $270 from $248 at Piper Sandler

TIPRANKS
·
01 Aug

Morgan Stanley Raises Price Target on ResMed to $298 From $291, Keeps Overweight Rating

MT Newswires Live
·
01 Aug

Resmed Inc : Bofa Global Research Raises Price Objective to $300 From $280

THOMSON REUTERS
·
01 Aug

Resmed’s Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating

TIPRANKS
·
01 Aug

ResMed price target raised to $298 from $274 at KeyBanc

TIPRANKS
·
01 Aug